Skip to main content

Articles

Page 37 of 74

  1. Ceftriaxone (CTRX) and ampicillin/sulbactam (ABPC/SBT) are recommended by various guidelines as the first-line antibiotics for community-acquired pneumonia (CAP). However, which of these antibiotics is more ef...

    Authors: Nobuyoshi Hamao, Isao Ito, Satoshi Konishi, Naoya Tanabe, Masahiro Shirata, Issei Oi, Mitsuhiro Tsukino, Hisako Matsumoto, Yoshiro Yasutomo, Seizo Kadowaki and Toyohiro Hirai
    Citation: BMC Pulmonary Medicine 2020 20:160
  2. Whereas Burkholderia infections are recognized to impair prognosis in cystic fibrosis (CF) patients, there is no recommendation to date for early eradication therapy. The aim of our study was to analyse the curre...

    Authors: Vianney Gruzelle, Hélène Guet-Revillet, Christine Segonds, Stéphanie Bui, Julie Macey, Raphaël Chiron, Marine Michelet, Marlène Murris-Espin and Marie Mittaine
    Citation: BMC Pulmonary Medicine 2020 20:159
  3. Lung cancer is frequently situated peripherally in the upper lobes of the lung. Acquiring adequate tissue from this difficult-to-reach area remains a challenge. Transbronchial cryobiopsy (TBCB) has the ability...

    Authors: Sze Shyang Kho, Chan Sin Chai, Larry Ellee Nyanti, Adam Malik bin Ismail and Siew Teck Tie
    Citation: BMC Pulmonary Medicine 2020 20:158
  4. Obstructive sleep apnoea (OSA) is related with adverse pregnancy outcomes, including preeclampsia. However, there are small studies about treatment of OSA with automatic continuous positive airway pressure (CP...

    Authors: Mi Sun Kim, Myoung Jin Moon, Yoon Hee Lee, Kyu Young Chae and Eun Hee Ahn
    Citation: BMC Pulmonary Medicine 2020 20:157
  5. Statin-associated necrotizing myopathy (SANM) is a rare autoimmune disorder caused by administration of statins. SANM is characterized by weakness due to necrosis and regeneration of myofibers. Here we report ...

    Authors: Yuriko Yamamura, Yoshinori Matsumoto, Koh Tadokoro, Yasuyuki Ohta, Kota Sato, Toru Yamashita, Masahiro Yamamura, Ken-Ei Sada, Koji Abe and Jun Wada
    Citation: BMC Pulmonary Medicine 2020 20:156
  6. Macitentan is a dual endothelin receptor antagonist indicated for the long-term treatment of pulmonary arterial hypertension (PAH). We evaluated the change over time in REVEAL risk score in incident and preval...

    Authors: Pilar Escribano-Subias, Raquel López, Luis Almenar, María Lázaro, Ian Forn, Anna Torrent, Isabel Blanco and Joan Albert Barberà
    Citation: BMC Pulmonary Medicine 2020 20:154
  7. Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies of different populations are important to understand the high variability in clinical presentation and disease cours...

    Authors: Hok Sreng Te, David M. Perlman, Chetan Shenoy, Daniel J. Steinberger, Rebecca J. Cogswell, Henri Roukoz, Erik J. Peterson, Lin Zhang, Tadashi L. Allen and Maneesh Bhargava
    Citation: BMC Pulmonary Medicine 2020 20:155
  8. Long non-coding RNA (lncRNA) Wilms Tumor 1 Associated Protein Pseudogene 1 (WTAPP1) has been reported to be a critical player in the angiogenesis and migration of endothelial progenitor cells, while its involv...

    Authors: Li Zhang, Chengyan Jin, Guiyun Yang, Bin Wang, Peiyan Hua and Yan Zhang
    Citation: BMC Pulmonary Medicine 2020 20:153
  9. Usual clinical practice for arterial blood gas analysis (BGA) in conscious patients involves a one-time arterial puncture to be performed after a resting period of 20–30 min. The aim of this study was to evalu...

    Authors: Akira Umeda, Masahiro Ishizaka, Masamichi Tasaki, Tateki Yamane, Taiji Watanabe, Yasushi Inoue, Taichi Mochizuki, Yasumasa Okada and Sarah Kesler
    Citation: BMC Pulmonary Medicine 2020 20:151
  10. Variants in the gene encoding bone morphogenetic protein receptor type II (BMPR2) are the most common genetic cause of pulmonary arterial hypertension (PAH), whereas biallelic variants in the eukaryotic translati...

    Authors: Qixian Zeng, Hang Yang, Bingyang Liu, Yanyun Ma, Zhihong Liu, Qianlong Chen, Wenke Li, Qin Luo, Zhihui Zhao, Zhou Zhou and Changming Xiong
    Citation: BMC Pulmonary Medicine 2020 20:150
  11. Vascular Ehlers-Danlos syndrome (vEDS) is a rare autosomal dominant hereditary collagen disease caused by a defect or deficiency in the pro-α1 chain of type III procollagen encoded by the COL3A1 gene. Patients...

    Authors: Tingting Wan, Jinyan Ye, Peiliang Wu, Mengshi Cheng, Baihong Jiang, Hailong Wang, Jianmin Li, Jun Ma, Liangxing Wang and Xiaoying Huang
    Citation: BMC Pulmonary Medicine 2020 20:149
  12. Forced expiratory volume in one second (FEV1) characterizes the pathophysiology of COPD and different trajectories of FEV1 decline have been observed in patients with COPD (e.g. gradual or episodic). There is lim...

    Authors: Johanna I. Lutter, Rudolf A. Jörres, Kathrin Kahnert, Larissa Schwarzkopf, Michael Studnicka, Stefan Karrasch, Holger Schulz, Claus F. Vogelmeier and Rolf Holle
    Citation: BMC Pulmonary Medicine 2020 20:148
  13. We assessed the rate of and predictors for all-cause mortality in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving plasma exchange (PLEX) and evaluated the surviva...

    Authors: Pil Gyu Park, Byung-Woo Yoo, Jason Jungsik Song, Yong-Beom Park and Sang-Won Lee
    Citation: BMC Pulmonary Medicine 2020 20:147
  14. Pulmonary tuberculosis is one of the most common infectious diseases worldwide. Patients with suspected pulmonary tuberculosis with negative smear are recommended to undergo further tests including sputum indu...

    Authors: Wen Luo, Yihua Lin, Zhibin Li, Wanyu Wang and Yonghong Shi
    Citation: BMC Pulmonary Medicine 2020 20:146
  15. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Smita Pakhale, Michael Armstrong, Crystal Holly, Rojiemiahd Edjoc, Ena Gaudet, Shawn Aaron, Giorgio Tasca, William Cameron and Louise Balfour
    Citation: BMC Pulmonary Medicine 2020 20:145

    The original article was published in BMC Pulmonary Medicine 2014 14:76

  16. Previous analyses of combined pulmonary fibrosis and emphysema (CPFE) cohorts have provided conflicting data on the survival of patients with CPFE. Therefore, the aim of this study was to investigate the clini...

    Authors: Yuichi Ikuyama, Atsuhito Ushiki, Makoto Kosaka, Jumpei Akahane, Yuichi Mukai, Taisuke Araki, Yoshiaki Kitaguchi, Kazunari Tateishi, Kazuhisa Urushihata, Masanori Yasuo, Hiroshi Yamamoto and Masayuki Hanaoka
    Citation: BMC Pulmonary Medicine 2020 20:144
  17. Supervised cardio-pulmonary rehabilitation may be safe and beneficial for people with pulmonary hypertension (PH) in groups 1 (pulmonary arterial hypertension) and 4 (chronic thromboembolic disease), particula...

    Authors: Gordon McGregor, Julie Bruce, Stuart Ennis, James Mason, Ranjit Lall, Chen Ji, Harbinder Sandhu, Kate Seers, Prithwish Banerjee, Alastair Canaway, Katie Booth, Stephanie J. C. Taylor, Elizabeth Robertson, Tamar Pincus, Sally Singh, David Fitzmaurice…
    Citation: BMC Pulmonary Medicine 2020 20:143
  18. Attenuated decreases in lung function can signal the onset of acute respiratory events known as pulmonary exacerbations (PEs) in children and adolescents with cystic fibrosis (CF). Univariate joint modeling fa...

    Authors: E. R. Andrinopoulou, J. P. Clancy and R. D. Szczesniak
    Citation: BMC Pulmonary Medicine 2020 20:142
  19. Primary Ciliary Dyskinesia (PCD) is also known as immotile-cilia syndrome, an autosomal recessive disorder of ciliary function, leading to mucus retention in the respiratory system in childhood. Our knowledge ...

    Authors: Fuad Al Mutairi, Randa Alkhalaf, Abdullah Alkhorayyef, Fayhan Alroqi, Alyafee Yusra, Muhammad Umair, Fetaini Nouf, Amjad Khan, Alharbi Meshael, Aleidi Hamad, Alaujan Monira, Abdulaziz Asiri, Kheloud M. Alhamoudi and Majid Alfadhel
    Citation: BMC Pulmonary Medicine 2020 20:141
  20. Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has been become an important procedure for the diagnosis and staging of lung cancer. Our research identified the effects of differen...

    Authors: Youzu Xu, Jian Lin, Meifang Chen, Haihong Zheng and Jiaxi Feng
    Citation: BMC Pulmonary Medicine 2020 20:140
  21. Asthma is a complex syndrome with multiple domains including symptoms, lung function, asthma control, and airway inflammation. A study of Fenom PROâ„¢, a novel monitor for exhaled nitric oxide (FeNO), provided a...

    Authors: Philip E. Silkoff, Mark Sarno, Solomon Ssenyange, Vivek Balasubramanyam, Brian Awabdy and Ryan Leard
    Citation: BMC Pulmonary Medicine 2020 20:139
  22. Fluoroquinolones (FQs) are potential drugs that inhibit DNA synthesis and are used in the treatment of multidrug-resistant tuberculosis (TB) and short-term anti-TB regimens. In recent years, a high proportion ...

    Authors: Saba Kabir, Zarfishan Tahir, Nadia Mukhtar, Muhammad Sohail, Muhammad Saqalein and Abdul Rehman
    Citation: BMC Pulmonary Medicine 2020 20:138
  23. The association between chronic obstructive pulmonary disease (COPD), lung function and risk of type 2 diabetes mellitus (T2DM) remains controversial. We performed a meta-analysis to clarify this issue.

    Authors: Yang Peng, Guo-Chao Zhong, Lingxiao Wang, Lijuan Guan, Ao Wang, Kai Hu and Jing Shen
    Citation: BMC Pulmonary Medicine 2020 20:137
  24. Patients with a primary spontaneous pneumothorax (PSP) who are treated with chest tube drainage are traditionally connected to an analogue chest drainage system, containing a water seal and using a visual meth...

    Authors: Dieuwertje Ruigrok, Peter W. A. Kunst, Marielle M. J. Blacha, Ben Tomlow, Jacobine W. Herbrink, Eva J. Japenga, Wim Boersma, Paul Bresser, Ivo van der Lee and Kris Mooren
    Citation: BMC Pulmonary Medicine 2020 20:136
  25. Revefenacin, a once-daily, long-acting muscarinic antagonist delivered via standard jet nebulizer, increased trough forced expiratory volume in 1 s (FEV1) in patients with moderate to very severe chronic obstruct...

    Authors: James F. Donohue, Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann and Glenn D. Crater
    Citation: BMC Pulmonary Medicine 2020 20:134
  26. COPD exacerbations have negative impact on patients’ survival. Several risk factors for grave outcomes of such exacerbations have been descried. Muscle dysfunction and mass loss were shown to impact negatively...

    Authors: N. Lasman, M. Shalom, N. Turpashvili, G. Goldhaber, Y. Lifshitz, E. Leibowitz, G. Berger, G. Saltzman-Shenhav, A. Brom, D. Cohen, C. Avaky and G. Segal
    Citation: BMC Pulmonary Medicine 2020 20:133
  27. Following publication of the original article [1], the authors have flagged that there is an error in Fig. 3.

    Authors: Takumi Yoshikawa, Mitsuo Otsuka, Hirofumi Chiba, Kimiyuki Ikeda, Yuki Mori, Yasuaki Umeda, Hirotaka Nishikiori, Koji Kuronuma and Hiroki Takahashi
    Citation: BMC Pulmonary Medicine 2020 20:131

    The original article was published in BMC Pulmonary Medicine 2020 20:27

  28. Home mechanical ventilation is a reliable treatment for patients suffering from chronic respiratory failure, improving survival and quality of life. Prevalence has been increasing worldwide as a result of evol...

    Authors: Luca Valko, Szabolcs Baglyas, Laszlo Kunos, Attila Terray-Horvath, Andras Lorx, Janos Gal and Wolfram Windisch
    Citation: BMC Pulmonary Medicine 2020 20:130
  29. Although typical and atypical CT image findings of COVID-19 are reported in current studies, the CT image features of COVID-19 overlap with those of viral pneumonia and other respiratory diseases. Hence, it is...

    Authors: Lin Luo, Zhendong Luo, Yizhen Jia, Cuiping Zhou, Jianlong He, Jianxun Lyu and Xinping Shen
    Citation: BMC Pulmonary Medicine 2020 20:129
  30. While antifibrotic drugs significantly decrease lung function decline in idiopathic pulmonary fibrosis (IPF), there is still an unmet need to halt disease progression. Antioxidative therapy with N-acetylcystei...

    Authors: Hanyu Shi, Dawei Yin, Francesco Bonella, Michael Kreuter, Ute Oltmanns, Xuren Li, Shouchun Peng and Luqing Wei
    Citation: BMC Pulmonary Medicine 2020 20:128
  31. Pulmonary tuberculosis (PTB) is frequently associated with chronic respiratory impairment despite microbiological cure. There are only a few clinical research studies that describe the course, type and severit...

    Authors: Celso Khosa, Nilesh Bhatt, Isabel Massango, Khalide Azam, Elmar Saathoff, Abhishek Bakuli, Friedrich Riess, Olena Ivanova, Michael Hoelscher and Andrea Rachow
    Citation: BMC Pulmonary Medicine 2020 20:127
  32. Improvement in health-related quality of life (HRQL) has been suggested as an alternative treatment goal of non-tuberculous mycobacterial pulmonary disease (NTM-PD). This study was performed to elucidate the l...

    Authors: Nakwon Kwak, Sung A Kim, Sun Mi Choi, Jinwoo Lee, Chang-Hoon Lee and Jae-Joon Yim
    Citation: BMC Pulmonary Medicine 2020 20:126
  33. High-concentration oxygen therapy causes increased arterial partial pressure of carbon dioxide (PaCO2) in patients with COPD, asthma, pneumonia, obesity and acute lung injury. The objective of these studies was t...

    Authors: Janine Pilcher, Darmiga Thayabaran, Stefan Ebmeier, Mathew Williams, Geraldine Back, Hamish Collie, Michael Richards, Susan Bibby, Ruth Semprini, Mark Weatherall and Richard Beasley
    Citation: BMC Pulmonary Medicine 2020 20:125
  34. Extracorporeal membrane oxygenation (ECMO) has been increasingly used for severe neonatal respiratory failure refractory to conventional treatments. To systematically evaluate the complications and mortality o...

    Authors: Jing Xiong, Li Zhang and Lei Bao
    Citation: BMC Pulmonary Medicine 2020 20:124
  35. Previous studies have established a higher prevalence of vitamin D deficiency in patients with COPD, but the relationship between vitamin D levels and COPD exacerbations remains controversial. In addition, the...

    Authors: Auyon J. Ghosh, Matthew Moll, Lystra P. Hayden, Jessica Bon, Elizabeth Regan and Craig P. Hersh
    Citation: BMC Pulmonary Medicine 2020 20:123
  36. Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the r...

    Authors: Sebastian Majewski, Adam J. BiaÅ‚as, MaÅ‚gorzata Buchczyk, PaweÅ‚ Gomółka, Katarzyna Górska, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz JastrzÄ™bski, Aleksander Kania, Marek Koprowski, RafaÅ‚ Krenke, Jan KuÅ›, Katarzyna Lewandowska, Magdalena M. Martusewicz-Boros, Kazimierz Roszkowski-Åšliż…
    Citation: BMC Pulmonary Medicine 2020 20:122
  37. An asymptomatic SCUBA (Self-contained underwater breathing apparatus) diver was discovered to have an intralobar bronchopulmonary sequestration during routine pre-course screening. This is the first reported c...

    Authors: Timothy Xin Zhong Tan, Andrew Yunkai Li, James Jie Sng, Mark Lim, Zhi Xiang Tan, Hope Xian’en Ang, Boon Hor Ho, David Zhiwei Law and Anne Ann Ling Hsu
    Citation: BMC Pulmonary Medicine 2020 20:121
  38. Although many studies on people with Chronic Obstructive Pulmonary Disease (COPD) have examined the mutual impact of physical status and emotional experience, there is limited knowledge about the way COPD peop...

    Authors: Marta Pozzar, Eleonora Volpato, Chiara Valota, Francesco Pagnini and Paolo Innocente Banfi
    Citation: BMC Pulmonary Medicine 2020 20:120
  39. Batefenterol (BAT) is a bi-functional molecule with both muscarinic antagonist and β2-adrenoceptor agonist pharmacology. This Phase II, randomized, placebo-controlled, double-blind study evaluated the safety and ...

    Authors: Courtney Crim, Mark Gotfried, Selwyn Spangenthal, Michael Watkins, Amanda Emmett, Catriona Crawford, Charlotte Baidoo and Ramiro Castro-Santamaria
    Citation: BMC Pulmonary Medicine 2020 20:119
  40. Electronic cigarettes/e-cigarettes (ECs), or vaping, is currently the most popular form of smoking amongst youth in the United States. ECs are battery-powered devices that vaporize a liquid that comes in small...

    Authors: Andrew L. Silverman, Haseeb Siddique, Vikas Kumar, Thuy-Hong Le and Joseph Ng
    Citation: BMC Pulmonary Medicine 2020 20:118
  41. Various host factors can promote pneumonia susceptibility of lung cancer patients. However, data about risk factors for pneumonia in lung cancer patients receiving active treatments such as chemotherapy, radio...

    Authors: Jung Won Heo, Chang Dong Yeo, Chan Kwon Park, Sung Kyoung Kim, Ju Sang Kim, Jin Woo Kim, Seung Joon Kim, Sang Haak Lee and Hye Seon Kang
    Citation: BMC Pulmonary Medicine 2020 20:117
  42. Pulmonary cryptococcosis is an uncommon infectious disease that can develop in both immunocompromised and immunocompetent patients. The severity of chronic kidney disease (CKD) was reported to be one of the ri...

    Authors: Hiroki Tashiro, Tetsuro Haraguchi, Koichiro Takahashi, Hironori Sadamatsu, Ryo Tajiri, Ayako Takamori, Shinya Kimura and Naoko Sueoka-Aragane
    Citation: BMC Pulmonary Medicine 2020 20:116
  43. Appropriate management of lung nodules detected incidentally or through lung cancer screening can increase the rate of early-stage diagnoses and potentially improve treatment outcomes. However, the implementat...

    Authors: Gregory P. LeMense, Ernest A. Waller, Cheryl Campbell and Tyler Bowen
    Citation: BMC Pulmonary Medicine 2020 20:115
  44. Handgrip strength (HGS) has been widely studied in clinical and epidemiological settings, but the relationship between HGS and pulmonary function is still controversial. This study analysed pulmonary function ...

    Authors: Liangmei Chen, Xiaomin Liu, Qian Wang, Linpei Jia, Kangkang Song, Sasa Nie, Yinping Zhang, Dan Cao, Delong Zhao, Zuoxiang Li, Zheyi Dong, Ying Zheng, Shuwei Duan, Xuefeng Sun, Zhe Feng, Guangyan Cai…
    Citation: BMC Pulmonary Medicine 2020 20:114
  45. The involvement of lncRNA FEZF1-AS1 has been analyzed in many types of cancers, while its roles in non-small cell lung cancer (NSCLC) remains unclear. We then explored the role of FEZF1-AS1 in NSCLC.

    Authors: Shangxiao Huang, Chunjun Li, Jianfeng Huang, Penghui Luo, Dunchang Mo and Hanlei Wang
    Citation: BMC Pulmonary Medicine 2020 20:110

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal